McDonald J.M. Modesitt S.C.

The incidental postmenopausal adnexal mass.

Clin Obstet Gynecol. 49: 506-516Naqvi J. Nagaraju E. Ahmad S.

MRI appearances of pure epithelial papillary serous borderline ovarian tumours.

Clin Radiol. 70: 424-432Koonings P.P. Campbell K. Mishell Jr., D.R. et al.

Relative frequency of primary ovarian neoplasms: a 10-year review.

Obstet Gynecol. 74: 921-926Hauptmann S. Friedrich K. Redline R. et al.

Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.

Virchows Arch. 470: 125-142Cheung A. Ellenson L.H. Gilks C.B.

WHO classification of tumours: female genital tumours.

5th edition. International Agency for Research on Cancer,

MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.

AJR Am J Roentgenol. 194: 311-321Tanaka Y.O. Okada S. Satoh T. et al.

Ovarian serous surface papillary borderline tumors form sea anemone-like masses.

J Magn Reson Imaging. 33: 633-640

Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.

Int J Gynecol Pathol. 27: 151-160Jung S.E. Lee J.M. Rha S.E. et al.

CT and MR imaging of ovarian tumors with emphasis on differential diagnosis.

Radiographics. 22: 1305-1325Vargas H.A. Barrett T. Sala E.

MRI of ovarian masses.

J Magn Reson Imaging. 37: 265-281Griffin N. Grant L.A. Sala E.

Adnexal masses: characterization and imaging strategies.

Semin Ultrasound CT MR. 31: 330-346Folkins A.K. Longacre T.A.

Low-grade Serous Neoplasia of the Female Genital Tract.

Surg Pathol Clin. 12: 481-513Khati N.J. Kim T. Riess J.

Imaging of Benign Adnexal Disease.

Radiol Clin North Am. 58: 257-273Tang Y.Z. Liyanage S. Narayanan P. et al.

The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patterns.

Eur Radiol. 23: 48-56Shimizu S. Okano H. Ishitani K. et al.

Ovarian cystadenofibroma with solid nodular components masqueraded as ovarian cancer.

Arch Gynecol Obstet. 279: 709-711Khashper A. Addley H.C. Abourokbah N. et al.

T2-hypointense adnexal lesions: an imaging algorithm.

Radiographics. 32: 1047-1064Flicek K.T. VanBuren W. Dudiak K. et al.

Borderline epithelial ovarian tumors: what the radiologist should know.

Abdom Radiol (Ny). 46: 2350-2366Mayr D. Hirschmann A. Löhrs U. et al.

KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.

Gynecol Oncol. 103: 883-887Zhao S.H. Qiang J.W. Zhang G.F. et al.

MRI appearances of ovarian serous borderline tumor: pathological correlation.

J Magn Reson Imaging. 40: 151-156Thomassin-Naggara I. Balvay D. Aubert E. et al.

Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.

Eur Radiol. 22: 738-745Seidman J.D. Horkayne-Szakaly I. Haiba M. et al.

The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin.

Int J Gynecol Pathol. 23: 41-44Tropé C.G. Kaern J. Davidson B.

Borderline ovarian tumours.

Best Pract Res Clin Obstet Gynaecol. 26: 325-336Prat J. D'Angelo E. Espinosa I.

Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.

Hum Pathol. 80: 11-27Garrett A.P. Lee K.R. Colitti C.R. et al.

k-ras mutation may be an early event in mucinous ovarian tumorigenesis.

Int J Gynecol Pathol. 20: 244-251

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications.

Ann Oncol. 28 ()Kurman RJ C.M. Herrington C.S. Young R.H. WHO classification of Tumours of Female Reproductive Organs. 4th edition. Lyon: International Agency for Research on Cancer, France

Mucinous Ovarian Tumors.

Surg Pathol Clin. 12: 565-585Dhanda S. Thakur M. Kerkar R. et al.

Diffusion-weighted imaging of gynecologic tumors: diagnostic pearls and potential pitfalls.

Radiographics. 34: 1393-1416Taylor E.C. Irshaid L. Mathur M.

Multimodality Imaging Approach to Ovarian Neoplasms with Pathologic Correlation.

Radiographics. 41: 289-315Ohya A. Ichinohe F. Matoba H. et al.

Useful preoperative examination findings to classify the grade of ovarian primary mucinous tumor.

Abdom Radiol (Ny). 46: 2393-2402Abdel Wahab C. Rousset P. Bolze P.A. et al.

[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].

Gynecol Obstet Fertil Senol. 48: 260-276Peng Y. Lin J. Guan J. et al.

Ovarian collision tumors: imaging findings, pathological characteristics, diagnosis, and differential diagnosis.

Abdom Radiol (Ny). 43: 2156-2168Dimova J. Zlatareva D. Bakalova R. et al.

Adnexal masses characterized on 3 tesla magnetic resonance imaging - added value of diffusion techniques.

Radiol Oncol. 54: 419-428Woodruff J.D. Dietrich D. Genadry R. et al.

Proliferative and malignant Brenner tumors. Review of 47 cases.

Am J Obstet Gynecol. 141: 118-125Montoriol P.F. Hordonneau C. Boudinaud C. et al.

Benign Brenner tumour of the ovary: CT and MRI features.

Clin Radiol. 76: 593-598Takahama J. Ascher S.M. Hirohashi S. et al.

Borderline Brenner tumor of the ovary: MRI findings.

Abdom Imaging. 29: 528-530Ricotta G. Maulard A. Genestie C. et al.

Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.

Ann Surg Oncol. 28: 6714-6720Yin Z. Peters S. Chokshi R. et al.

Ovarian Clear Cell Adenofibroma of Low Malignant Potential Developing Into Clear Cell Adenocarcinoma.

Int J Surg Pathol. 26: 578-580Takeuchi M. Matsuzaki K. Uehara H. et al.

Clear cell adenocarcinoma arising from clear cell adenofibroma of the ovary: value of DWI and DCE-MRI.

Magn Reson Med Sci. 12: 305-308Ricotta G. Maulard A. Candiani M. et al.

Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management.

Ann Surg Oncol. 29: 1165-1170

Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues.

Diagnostics (Basel). 10Kurata Y. Kido A. Moribata Y. et al.

Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.

Magn Reson Med Sci. 17: 211-217

Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases.

Am J Surg Pathol. 9: 205-214Matias-Guiu X. Stewart C.J.R.

Endometriosis-associated ovarian neoplasia.

Pathology. 50: 190-204Nakagawa E. Abiko K. Kido A. et al.

Four cases of endometrioid borderline ovarian tumour: case reports and literature review.

BJR Case Rep. 4: 20170062

Pathology of Ovarian Cancer: Recent Insights Unveiling Opportunities in Prevention.

Clin Obstet Gynecol. 60: 686-696Brun J.L. Fritel X. Aubard Y. et al.

Management of presumed benign ovarian tumors: updated French guidelines.

Eur J Obstet Gynecol Reprod Biol. 183: 52-58Beroukhim G. Ozgediz D. Cohen P.J. et al.

Progression of Cystadenoma to Mucinous Borderline Ovarian Tumor in Young Females: Case Series and Literature Review.

J Pediatr Adolesc Gynecol. 35: 359-367

Mucinous tumors of the ovary: current thoughts on diagnosis and management.

Curr Oncol Rep. 16: 389Bourdel N. Huchon C. Abdel Wahab C. et al.

Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).

Eur J Obstet Gynecol Reprod Biol. 256: 492-501Chevrot A. Pouget N. Bats A.S. et al.

Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.

Gynecol Oncol. 157: 29-35Patrono M.G. Minig L. Diaz-Padilla I. et al.

Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment.

Ecancermedicalscience. 7: 379Vasconcelos I. de Sousa Mendes M.

Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.

Eur J Cancer. 51: 620-631Daraï E. Fauvet R. Uzan C. et al.

Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options.

Hum Reprod Update. 19: 151-166Palomba S. Falbo A. Del Negro S. et al.

Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up.

Hum Reprod. 25: 1966-1972deSouza N.M. O'Neill R. McIndoe G.A. et al.

Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease.

AJR Am J Roentgenol. 184: 999-1003

Serous and mucinous borderline (low malignant potential) tumors of the ovary.

Am J Clin Pathol. 123: S13-S57Chen V.W. Ruiz B. Killeen J.L. et al.

Pathology and classification of ovarian tumors.

Cancer. 97: 2631-2642Cadron I. Leunen K. Van Gorp T. et al.

Management of borderline ovarian neoplasms.

J Clin Oncol. 25: 2928-2937Alvarez R.M. Vazquez-Vicente D.

Fertility sparing treatment in borderline ovarian tumours.

Ecancermedicalscience. 9: 507Lenhard M.S. Mitterer S. Kümper C. et al.

Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort.

Eur J Obstet Gynecol Reprod Biol. 145: 189-194Feigenberg T. Covens A. Ghorab Z. et al.

Is routine appendectomy at the time of primary surgery for mucinous ovarian neoplasms beneficial?.

Int J Gynecol Cancer. 23: 1205-1209McEvoy S.H. Nougaret S. Abu-Rustum N.R. et al.

Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Abdom Radiol (Ny). 42: 2488-2512Alves A.S. Félix A. Cunha T.M.

Clues to the diagnosis of borderline ovarian tumours: An imaging guide.

Eur J Radiol. 143109904Lesieur B. Kane A. Duvillard P. et al.

Prognostic value of lymph node involvement in ovarian serous borderline tumors.

Am J Obstet Gynecol. 204 ()

NCCN Guideline for Patients Ovarian Cancer.

() ()